OBJECTIVES: Vasoactive drugs are often initiated during prehospital post-resuscitation care by Helicopter Emergency Medical Services (HEMS). Evidence is limited regarding treatment targets to ensure optimised survival. Hence, guidelines remain vague. We aimed to compare 30-day and 1-day mortality based on systolic blood pressure (SBP) attained after the administration of vasoactive medication during prehospital post-resuscitation care. METHODS: We conducted a retrospective registry-based cohort study including post-resuscitation care cases attended by a HEMS-physician in which vasoactive treatment was used between 1.1.2012 and 31.8.2019. Patients were categorised according to SBP at handover to hospital: <
100, 100-119, 120-140, >
140mmHg. Multivariate logistic regression was used to assess 30- and 1-day mortality, while controlling for age, sex, time to return of spontaneous circulation, presumed cardiac aetiology for arrest, whether the arrest was witnessed, initial rhythm and presence of bystander cardiopulmonary resuscitation. RESULTS: 3029 post-resuscitation cases were attended by HEMS. In these cases, a total of 1861 patients received vasoactive medication. 1665 patients had necessary variables recorded and were included in our primary analysis. Compared to hypotensive (SBP<
100mmHg), odds ratios for 30-day mortalities were 0.54 (0.37-0.80), 0.58 (0.40 - 0.85), and 0.78 (0.51-1.18) in respective SBP categories of 100-119, 120-140 and >
140mmHg. Furthermore, odds ratios for 1-day mortalities were 0.42 (0.28-0.61), 0.42 (0.29-0.61), and 0.36 (0.23-0.55), respectively. CONCLUSIONS: Normotension (SBP 100-140mmHg) was associated with lower mortality compared to hypo- and hypertensive patients. This can be considered a basis for future prospective trials.